Biosimilars

Latest News

Rx Roundup: Quiz of the Week — March 8, 2024
Rx Roundup: Quiz of the Week — March 8, 2024

March 8th 2024

Test your pharmacy news knowledge with our weekly quiz.

Tocilizumab-aazg Is First IV, Subcutaneous Tocilizumab Biosimilar With FDA Approval
Tocilizumab-aazg Is First IV, Subcutaneous Tocilizumab Biosimilar With FDA Approval

March 7th 2024

FDA Approves Interchangeable Denosumab Biosimilar
FDA Approves Interchangeable Denosumab Biosimilar

March 5th 2024

FDA: Simlandi Becomes Third Interchangeable Humira Biosimilar After Approval
FDA: Simlandi Becomes Third Interchangeable Humira Biosimilar After Approval

February 26th 2024

2024 Formulary Changes
2024 Formulary Changes

February 23rd 2024

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.